Clinical strategy of diagnosing and following patients with nonalcoholic fatty liver disease based on invasive and noninvasive methods

@inproceedings{Yoneda2017ClinicalSO,
  title={Clinical strategy of diagnosing and following patients with nonalcoholic fatty liver disease based on invasive and noninvasive methods},
  author={Masato Yoneda and Kento Imajo and Hirokazu Takahashi and Yuji Ogawa and Yuichiro Eguchi and Yoshio Sumida and Masashi Yoneda and Miwa Kawanaka and Satoru Saito and Katsutoshi Tokushige and Atsushi Nakajima},
  booktitle={Journal of Gastroenterology},
  year={2017}
}
Nonalcoholic fatty liver disease (NAFLD) is an important cause of chronic liver injury in many countries. The incidence of NAFLD is rising rapidly in both adults and children, because of the currently ongoing epidemics of obesity and type 2 diabetes. Notably, histological liver fibrosis is recognized as the main predictive factor for the overall long-term outcome of NAFLD, including cardiovascular disease and liver-related mortality. Thus, staging of liver fibrosis is essential in determining… CONTINUE READING

References

Publications referenced by this paper.
Showing 1-10 of 126 references

Long-Term Outcomes of Nonalcoholic Fatty Liver Disease: From Nonalcoholic Steatohepatitis to Nonalcoholic Steatofibrosis.

Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association • 2017
View 1 Excerpt

Similar Papers

Loading similar papers…